Anebulo Pharmaceuticals, Inc. ANEB
0.28 USD +0.02 (+5.77%)
At closeNov 6, 2026, 4:00 PM EST
0.38 +0.11 +38.87%
After hours · Nov 6, 4:00 PM ET
0.8699 Day range 0.8699
0.001 52-week range 2.49
- YTD
- -72.77%
- 1 year
- -89.00%
News
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session 
benzinga.com Anebulo Pharmaceuticals Q2 EPS $(0.05) Beats $(0.13) Estimate Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.13) by 61.54 percent. This is a 44.44 percent increase over…
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session 
benzinga.com Anebulo Pharmaceuticals Voluntarily Delisting Common Shares From Nasdaq, Effective Feb. 27 Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the "Company" or…- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com How Do Investors Really Feel About Anebulo Pharmaceuticals Inc?
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com How Is The Market Feeling About Anebulo Pharmaceuticals Inc?
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com Crude Oil Jumps 2%; Chicago Fed National Activity Index Improves Slightly In September - benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com US Stocks Higher; Nasdaq Surges Over 100 Points 
benzinga.com Anebulo To Commence $3.50/Shr Cash Tender Offer For Up To 300K Shares As Part Of Plan To Go Private In Lieu Of Reverse Stock Split At Ratio Of Not Less Than 1-For-2,500 And Not Greater Than 1-For-7,500 Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the "Company" or…
benzinga.com Anebulo Pharmaceuticals Q1 EPS $(0.05) Beats $(0.12) Estimate Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.12) by 58.33 percent. This is a 37.5 percent increase over losses…
benzinga.com Deal Dispatch: Need M&A Approval? FCC Chair Explains How To Get It The "Jimmy Kimmel Live" drama coincided with reports of tit-for-tat maneuvering between the FCC and corporations desperate for deal approval.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.- benzinga.com Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the…
- benzinga.com Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
- benzinga.com Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session Gainers Summit Therapeutics Inc. (NASDAQ: SMMT) shares surged 82.2% to $1.4299 after the company announced a definitive agreement of its partnership with Akeso to in-license its breakthrough…
- benzinga.com Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday Gainers
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 120 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 200 companies hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's session, 78 companies made new 52-week lows.
- benzinga.com Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per…
- benzinga.com Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2022
- benzinga.com Tesla, Ra Medical Systems And 51 Stocks Moving In Tuesday's Mid-Day Session Gainers Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 69.6% to $0.5240 after the company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter.